Huizenga Theodore Alan

Avg. Two Year Performance

No purchase track record

12% Avg. Sale Return

6% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	3%	3%	4%	12%	12%
Sale Success Rate	5 of 15	5 of 15	5 of 15	5 of 15	6 of 15

Ultragenyx Pharmaceutical I...

Drugs » Biotechnology

SVP, Chief Accounting Officer:

Holdings: 42.25K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--